Chugai Of Japan To Make Japan-Specific Version Of Tamiflu
This article was originally published in PharmAsia News
Executive Summary
Japan's Chugai Pharmaceutical plans to produce a version of Roche's Tamiflu (oseltamivir) antiviral modified to deal with the nation's hot and humid weather. Chugai, a subsidiary of Roche, expects to deliver its specially designed version in October in a dry syrup form. The production line to be used is capable of producing enough doses per month to treat 500,000 people. Chugai plans to modify the dry syrup it gets from Switzerland so it can be stored at room temperature instead of needing to be refrigerated. (Click here for more - a subscription may be required